Interstitial granulomatous dermatitis during talimogen laherparepvec treatment

Melanoma Research

Volumn 27, Issue 4, 2017, Pages 400-401

  Frauchiger, Anna L ^a   Brüggen, Marie Charlotte ^a   Goldinger, Simone M ^a   Dummer, Reinhard ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; C REACTIVE PROTEIN; CD4 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; MOMETASONE FUROATE; PEMBROLIZUMAB; TALIMOGENE LAHERPAREPVEC; GAMMA 34.5 PROTEIN, HUMAN HERPESVIRUS 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ICP47 PROTEIN, HERPES SIMPLEX VIRUS; IMMEDIATE EARLY PROTEIN; VIRAL PROTEIN;

ADULT; CASE REPORT; CHILL; DERMATITIS; FEVER; HUMAN; IMMUNOHISTOCHEMISTRY; INTERSTITIAL GRANULOMATOUS DERMATITIS; LETTER; LYMPH NODE DISSECTION; LYMPHOCYTE; MACROPHAGE; MALE; MELANOMA; NAUSEA; PRIORITY JOURNAL; RASH; WIDE EXCISION; CHEMICALLY INDUCED; FATALITY; GENETICS; GRANULOMA; ONCOLYTIC VIROTHERAPY; SKIN TUMOR;

ADULT; DERMATITIS; FATAL OUTCOME; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GRANULOMA; HUMANS; IMMEDIATE-EARLY PROTEINS; MALE; MELANOMA; ONCOLYTIC VIROTHERAPY; SKIN NEOPLASMS; VIRAL PROTEINS;

EID: 85020225444     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/CMR.0000000000000369     Document Type: Letter

References (6)

1. Andtbacka RH, Kaufman HL, Collichio F, Amatruda T, Senzer N, Chesney J, et al. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma. J Clin Oncol 2015; 33:2780-2788.
2. Long GV, Dummer R, Ribas A, Puzanov I, Michielin O, Vanderwalde AM, et al. A phase 1/3 multicenter trial of talimogene laherparepvec in combination with pembrolizumab for unresected, stage IIIB-IV melanoma (MASTERKEY-265). 2016 ASCO Annual Meeting (Poster) 2016.
3. Kohlhapp FJ, Kaufman HL. Molecular pathways: Mechanism of action for talimogene laherparepvec, a new oncolytic virus immunotherapy. Clin Cancer Res 2016; 22:1048-1054.
4. Rosenbach M, English JC 3rd. Reactive granulomatous dermatitis: A review of palisaded neutrophilic and granulomatous dermatitis, interstitial granulomatous dermatitis, interstitial granulomatous drug reaction, and a proposed reclassification. Dermatol Clin 2015; 33:373-387.
5. Ushach I, Zlotnik A. Biological role of granulocyte macrophage colonystimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage. J Leukoc Biol 2016; 100:481-489.
6. Croxford AL, Lanzinger M, Hartmann FJ, Schreiner B, Mair F, Pelczar P, et al. The cytokine GM-CSF drives the inflammatory signature of CCR2 + monocytes and licenses autoimmunity. Immunity 2015; 43:502-514.